As the CMIV researchers are also affiliated to a home department at Linköping University or another university and their research is primarily registered there it can be difficult to overview. Here you will find a selection of the latest publications registered in the DiVA database.
Three-dimensional echocardiography to identify right ventricular dilatation in patients with corrected Fallot anomaly or pulmonary stenosis
Background 3-Dimensional Echocardiography allows measuring volumes and parameters of myocardial deformation (strain). Myocardial strain has been suggested to be superior to conventional echo parameters in the assessment of right ventricular (RV) function. Myocardial strain can be assessed by cardiac magnetic resonance (CMR) or two- and three-dimensional echocardiography (2D and 3DEcho). We performed a comprehensive assessment of the RV based on 3DEcho and compared the results with those based on CMR and 2DEcho. Methods 36 patients with corrected heart defects underwent CMR and 3DEcho to assess RV volume, strain and cardio pulmonary exercise testing with peak VO2 measurement. 2DEcho was used for reference. Results There was a moderate correlation between 3DEcho and CMR for measuring RV end-diastolic and end-systolic volumes (r = .82 and .72). 3DEcho tended to underestimate the RV volumes, mean difference EDV 8.5 +/- 33 ml (CI -2.8; 19.7 ml) and ESV 13.2 +/- 29 ml (CI 3.3; 23 ml). According to method-specific reference values for RVEDV, 34/35 (3DEcho) and 29/36 (CMR) were dilated. Among those dilated according to CMR, all were identified by 3DEcho. The coefficient of correlation between RV atrioventricular plane displacement measured by CMR and tricuspid annular plane systolic excursion measured by 3D and 2DEcho was r = .6 for both. 2DEcho measured lower LV volumes than CMR. LVEF and GLS were similar in 2DEcho, 3DEcho and CMR. Patients with CMR-determined RV free wall strain <= -14% tended to have lower peak VO2. Conclusions Although 3DEcho underestimated RV volumes, it successfully identified all patients with RV dilatation based on method-specific reference values.Publication in DiVA
Signal-To-Noise Ratio Rate Measurement in Fluoroscopy For Quality Control and Teaching Good Radiological Imaging Technique
Visibility of low-contrast details in fluoroscopy and interventional radiology is important. Assessing detail visibility with human observers typically suffers from large observer variances. Objective, quantitative measurement of low-contrast detail visibility using a model observer, such as the square of the signal-to-noise ratio rate (SNR2rate), was implemented in MATLAB™ and evaluated. The expected linear response of SNR2rate based on predictions by the so-called Rose model and frame statistics was verified. The uncertainty in the measurement of SNR2rate for a fixed imaging geometry was 6% based on 16 repeated measurements. The results show that, as expected, reduced object thickness and x-ray field size substantially improved SNR2rate/PKA,rate with PKA,rate being the air kerma area product rate. The measurement precision in SNR2rate/PKA,rate (8–9%) is sufficient to detect small but important improvements, may guide the selection of better imaging settings and provides a tool for teaching good radiological imaging techniques to clinical staff.Publication in DiVA
Ibandronate Reduces the Surface Bone Resorption of Mandibular Bone Grafts : A Randomized Trial With Internal Controls
ABSTRACT Autologous bone grafts are considered the gold standard for reconstruction of the edentulous alveolar ridges. However, this procedure is associated with unpredictable bone loss caused by physiological bone resorption. Bisphosphonates are antiresorptive drugs that act specifically on osteoclasts, thereby maintaining bone density, volume, and strength. It was hypothesized that the resorption of bone grafts treated with an ibandronate solution would be less advanced than bone grafts treated with saline. Ten patients who underwent bilateral sagittal split osteotomy were included in a randomized double-blind trial with internal controls. Each patient received a bone graft treated with a solution of ibandronate on one side and a graft treated with saline (controls) contralaterally. Radiographs for the measurement of bone volume were obtained at 2âweeks and at 6 months after surgery. The primary endpoint was the difference in the change of bone volume between the control and the ibandronate bone grafts 6 months after surgery. All of the bone grafts healed without complications. One patient was excluded because of reoperation. In eight of the nine patients, the ibandronate bone grafts showed an increase in bone volume compared with baseline, with an average gain of 126âmm3 (40% more than baseline) with a range of +27 to +218âmm3. Only one ibandronate-treated graft had a decrease in bone volume (8%). In the controls, an average bone volume loss of â146âmm3 (58% of baseline) with a range of â29 to â301âmm3 was seen. In the maxillofacial field, the reconstructions of atrophic alveolar ridges, especially in the esthetical zones, are challenging. These results show that bone grafts locally treated with ibandronate solution increases the remaining bone volume. This might lead to new possibilities for the maxillofacial surgeons in the preservation of bone graft volumes and for dental implant installations. Â© 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.Publication in DiVA